[{"doi":"10.1128/aac.05175-11","url":"http://dx.doi.org/10.1128/aac.05175-11","authors":[{"given":"Junni","family":"Mai","sequence":"first","affiliation":[{"name":"Department of Applied Oral Sciences, Dalhousie University, Halifax, Canada"},{"name":"Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, China"}]},{"given":"Xiao-Lin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Applied Oral Sciences, Dalhousie University, Halifax, Canada"}]},{"given":"Jeffrey W.","family":"Gallant","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Nadine","family":"Merkley","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Zakia","family":"Biswas","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Raymond","family":"Syvitski","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Susan E.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada"},{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Junqi","family":"Ling","sequence":"additional","affiliation":[{"name":"Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, China"}]},{"given":"Yung-Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Applied Oral Sciences, Dalhousie University, Halifax, Canada"},{"name":"Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada"}]}],"year":"2011","date":[2011,11],"language":"en","issn":"0066-4804","issue":"11","title":["A Novel Target-Specific, Salt-Resistant Antimicrobial Peptide against the Cariogenic Pathogen Streptococcus mutans"],"type":"journal-article","publisher":"American Society for Microbiology","volume":"55","abstract":"<jats:title>ABSTRACT</jats:title>\n          <jats:p>\n            In this study, we constructed and evaluated a target-specific, salt-resistant antimicrobial peptide (AMP) that selectively targeted\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Streptococcus mutans</jats:named-content>\n            , a leading cariogenic pathogen. The rationale for creating such a peptide was based on the addition of a targeting domain of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            ComC signaling peptide pheromone (CSP) to a killing domain consisting of a portion of the marine-derived, broad-spectrum AMP pleurocidin to generate a target-specific AMP. Here, we report the results of our assessment of such fusion peptides against\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            and two closely related species. The results showed that nearly 95% of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            cells lost viability following exposure to fusion peptide IMB-2 (5.65 μM) for 15 min. In contrast, only 20% of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. sanguinis</jats:named-content>\n            or\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. gordonii</jats:named-content>\n            cells were killed following the same exposure. Similar results were also observed in dual-species mixed cultures of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            with\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. sanguinis</jats:named-content>\n            or\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. gordonii</jats:named-content>\n            . The peptide-guided killing was further confirmed in\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            biofilms and was shown to be dose dependent. An\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            mutant defective in the CSP receptor retained 60% survival following exposure to IMB-2, suggesting that the targeted peptide predominantly bound to the CSP receptor to mediate killing in the wild-type strain. Our work confirmed that IMB-2 retained its activity in the presence of physiological or higher salt concentrations. In particular, the fusion peptide showed a synergistic killing effect on\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            with a preventive dose of NaF. In addition, IMB-2 was relatively stable in the presence of saliva containing 1 mM EDTA and did not cause any hemolysis. We also found that replacement of serine-14 by histidine improved its activity at lower pH. Because of its effectiveness, salt resistance, and minimal toxicity to host cells, this novel target-specific peptide shows promise for future development as an anticaries agent.\n          </jats:p>","page":"5205-5213"},{"doi":"10.1128/aem.01156-08","url":"http://dx.doi.org/10.1128/aem.01156-08","authors":[{"given":"Xin","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Microbiology, College of Life Sciences, Key Laboratory for Microbiological Engineering of Agricultural Environment of Ministry of Agriculture, Nanjing Agricultural University, 6 Tongwei Road, Nanjing, Jiangsu 210095, People's Republic of China"}]},{"given":"Hao-Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Life Sciences, Key Laboratory for Microbiological Engineering of Agricultural Environment of Ministry of Agriculture, Nanjing Agricultural University, 6 Tongwei Road, Nanjing, Jiangsu 210095, People's Republic of China"}]},{"given":"Qing","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Life Sciences, Key Laboratory for Microbiological Engineering of Agricultural Environment of Ministry of Agriculture, Nanjing Agricultural University, 6 Tongwei Road, Nanjing, Jiangsu 210095, People's Republic of China"}]},{"given":"Shun-Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Life Sciences, Key Laboratory for Microbiological Engineering of Agricultural Environment of Ministry of Agriculture, Nanjing Agricultural University, 6 Tongwei Road, Nanjing, Jiangsu 210095, People's Republic of China"}]}],"year":2008,"date":[2008,9],"language":"en","issn":"0099-2240","issue":"17","title":["Cre/\n            <i>lox</i>\n            System and PCR-Based Genome Engineering in\n            <i>Bacillus subtilis</i>"],"type":"journal-article","publisher":"American Society for Microbiology","volume":"74","abstract":"<jats:title>ABSTRACT</jats:title>\n          <jats:p>\n            We have developed a fast and accurate method to engineer the\n            <jats:italic>Bacillus subtilis</jats:italic>\n            genome that involves fusing by PCR two flanking homology regions with an antibiotic resistance gene cassette bordered by two mutant\n            <jats:italic>lox</jats:italic>\n            sites (\n            <jats:italic>lox71</jats:italic>\n            and\n            <jats:italic>lox66</jats:italic>\n            ). The resulting PCR products were used directly to transform\n            <jats:italic>B. subtilis</jats:italic>\n            , and then transient Cre recombinase expression in the transformants was used to recombine\n            <jats:italic>lox71</jats:italic>\n            and\n            <jats:italic>lox66</jats:italic>\n            into a double-mutant\n            <jats:italic>lox72</jats:italic>\n            site, thereby excising the marker gene. The mutation process could also be accomplished in 2 days by using a strain containing a\n            <jats:italic>cre</jats:italic>\n            isopropyl-β-\n            <jats:sc>d</jats:sc>\n            -thiogalactopyranoside (IPTG)-inducible expression cassette in the chromosome as the recipient or using the\n            <jats:italic>lox</jats:italic>\n            site-flanked cassette containing both the\n            <jats:italic>cre</jats:italic>\n            IPTG-inducible expression cassette and resistance marker. The in vivo recombination efficiencies of different\n            <jats:italic>lox</jats:italic>\n            pairs were compared; the\n            <jats:italic>lox72</jats:italic>\n            site that remains in the chromosome after Cre recombination had a low affinity for Cre and did not interfere with subsequent rounds of Cre/\n            <jats:italic>lox</jats:italic>\n            mutagenesis. We used this method to inactivate a specific gene, to delete a long fragment, to realize the in-frame deletion of a target gene, to introduce a gene of interest, and to carry out multiple manipulations in the same background. Furthermore, it should also be applicable to large genome rearrangement.\n          </jats:p>","page":"5556-5562","subject":["Ecology","Applied Microbiology and Biotechnology","Food Science","Biotechnology"]},{"doi":"10.1128/aac.05175-11","url":"http://dx.doi.org/10.1128/aac.05175-11","authors":[{"given":"Junni","family":"Mai","sequence":"first","affiliation":[{"name":"Department of Applied Oral Sciences, Dalhousie University, Halifax, Canada"},{"name":"Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, China"}]},{"given":"Xiao-Lin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Applied Oral Sciences, Dalhousie University, Halifax, Canada"}]},{"given":"Jeffrey W.","family":"Gallant","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Nadine","family":"Merkley","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Zakia","family":"Biswas","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Raymond","family":"Syvitski","sequence":"additional","affiliation":[{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Susan E.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada"},{"name":"Institute for Marine Biosciences, National Research Council of Canada, Halifax, Canada"}]},{"given":"Junqi","family":"Ling","sequence":"additional","affiliation":[{"name":"Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, China"}]},{"given":"Yung-Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Applied Oral Sciences, Dalhousie University, Halifax, Canada"},{"name":"Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada"}]}],"year":2011,"date":[2011,11],"language":"en","issn":"0066-4804","issue":"11","title":["A Novel Target-Specific, Salt-Resistant Antimicrobial Peptide against the Cariogenic Pathogen Streptococcus mutans"],"type":"journal-article","publisher":"American Society for Microbiology","volume":"55","abstract":"<jats:title>ABSTRACT</jats:title>\n          <jats:p>\n            In this study, we constructed and evaluated a target-specific, salt-resistant antimicrobial peptide (AMP) that selectively targeted\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Streptococcus mutans</jats:named-content>\n            , a leading cariogenic pathogen. The rationale for creating such a peptide was based on the addition of a targeting domain of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            ComC signaling peptide pheromone (CSP) to a killing domain consisting of a portion of the marine-derived, broad-spectrum AMP pleurocidin to generate a target-specific AMP. Here, we report the results of our assessment of such fusion peptides against\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            and two closely related species. The results showed that nearly 95% of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            cells lost viability following exposure to fusion peptide IMB-2 (5.65 μM) for 15 min. In contrast, only 20% of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. sanguinis</jats:named-content>\n            or\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. gordonii</jats:named-content>\n            cells were killed following the same exposure. Similar results were also observed in dual-species mixed cultures of\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            with\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. sanguinis</jats:named-content>\n            or\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. gordonii</jats:named-content>\n            . The peptide-guided killing was further confirmed in\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            biofilms and was shown to be dose dependent. An\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            mutant defective in the CSP receptor retained 60% survival following exposure to IMB-2, suggesting that the targeted peptide predominantly bound to the CSP receptor to mediate killing in the wild-type strain. Our work confirmed that IMB-2 retained its activity in the presence of physiological or higher salt concentrations. In particular, the fusion peptide showed a synergistic killing effect on\n            <jats:named-content xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. mutans</jats:named-content>\n            with a preventive dose of NaF. In addition, IMB-2 was relatively stable in the presence of saliva containing 1 mM EDTA and did not cause any hemolysis. We also found that replacement of serine-14 by histidine improved its activity at lower pH. Because of its effectiveness, salt resistance, and minimal toxicity to host cells, this novel target-specific peptide shows promise for future development as an anticaries agent.\n          </jats:p>","page":"5205-5213","subject":["Infectious Diseases","Pharmacology (medical)","Pharmacology"]}]